Split History
ETFs Holding VIVE »    VIVE Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Viveve Medical is a holding company. Through its subsidiaries, Co. designs, develops, manufactures and markets a platform medical technology, which it refers to as Cryogen-cooled Monopolar Radiofrequency (CMRF). Co.'s proprietary CMRF technology is delivered through a radiofrequency generator, handpiece and treatment tip, that collectively, Co. refers to as the Viveve® System. The Viveve System is for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence depending on the relevant country-specific clearance or approval, that Co. refers to as the Viveve treatment. According to our VIVE split history records, VIVE has had 3 splits.
VIVE split history picture
VIVE (VIVE) has 3 splits in our VIVE split history database. The first split for VIVE took place on April 18, 2016. This was a 1 for 8 reverse split, meaning for each 8 shares of VIVE owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 125 share position following the split. VIVE's second split took place on September 19, 2019. This was a 1 for 100 reverse split, meaning for each 100 shares of VIVE owned pre-split, the shareholder now owned 1 share. For example, a 125 share position pre-split, became a 1.25 share position following the split. VIVE's third split took place on December 02, 2020. This was a 1 for 10 reverse split, meaning for each 10 shares of VIVE owned pre-split, the shareholder now owned 1 share. For example, a 1.25 share position pre-split, became a 0.125 share position following the split.

When a company such as VIVE conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the VIVE split history from start to finish, an original position size of 1000 shares would have turned into 0.125 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into VIVE shares, starting with a $10,000 purchase of VIVE, presented on a split-history-adjusted basis factoring in the complete VIVE split history. VIVE split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 02/04/2013
End date: 01/31/2023
Start price/share: $1,040.00
End price/share: $0.11
Dividends collected/share: $0.00
Total return: -99.99%
Average Annual Total Return: -60.06%
Starting investment: $10,000.00
Ending investment: $1.04
Years: 9.99
Date Ratio
04/18/20161 for 8
09/19/20191 for 100
12/02/20201 for 10
Liminal BioSciences Inc. (LMNL)
Galway Metals Inc. (GWM.CA)
Lannett Company, Inc. (LCI)
Reed's, Inc. (REED)
Phio Pharmaceuticals Corp. (PHIO)
Swvl Holdings Corp (SWVL)
Sientra, Inc. (SIEN)
Eargo, Inc. (EAR)
Alterity Therapeutics Limited (ATHE)
Aytu BioPharma, Inc. (AYTU)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

VIVE Insider Buying

VIVE Split History | www.SplitHistory.com | Copyright © 2013 - 2023, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.